E. H. Biberoglu Et Al. , "Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet," GYNECOLOGICAL ENDOCRINOLOGY , vol.32, no.1, pp.55-57, 2016
Biberoglu, E. H. Et Al. 2016. Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet. GYNECOLOGICAL ENDOCRINOLOGY , vol.32, no.1 , 55-57.
Biberoglu, E. H., Tanrikulu, F., ERDEM, M., ERDEM, A., & Biberoglu, K. O., (2016). Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet. GYNECOLOGICAL ENDOCRINOLOGY , vol.32, no.1, 55-57.
Biberoglu, Ebru Et Al. "Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet," GYNECOLOGICAL ENDOCRINOLOGY , vol.32, no.1, 55-57, 2016
Biberoglu, Ebru H. Et Al. "Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet." GYNECOLOGICAL ENDOCRINOLOGY , vol.32, no.1, pp.55-57, 2016
Biberoglu, E. H. Et Al. (2016) . "Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet." GYNECOLOGICAL ENDOCRINOLOGY , vol.32, no.1, pp.55-57.
@article{article, author={Ebru H. Biberoglu Et Al. }, title={Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet}, journal={GYNECOLOGICAL ENDOCRINOLOGY}, year=2016, pages={55-57} }